CX NEWS
Remembering that “babies are not little adults” at CX Paediatric Vascular Emergencies and Case Presentations
The particular complexities of dealing with paediatric vessels were discussed in depth at Tuesday’s varied and informative CX Paediatric Vascular Emergencies and Case Presentations session. Covering topics as diverse as acute ischaemia from pre-term [...]
Watch and learn: CX Aortic Edited Cases
Tuesday’s CX Aortic Edited Cases session featured exciting and engaging standing-room only case presentations, including Andrew Holden’s (Auckland, New Zealand) first-in-man implantation of the Ovation Alto (Endologix). Covering thoracic, juxtarenal and abdominal cases, the [...]
ATTRACT trial results presented at CX
Suresh Vedantham Delegates heard yesterday the results of the ATTRACT randomised controlled trial, which showed that the addition of catheter-based intervention to anticoagulation failed to significantly decrease the occurrence of post-thrombotic syndrome [...]
CX audience homes in on grey area between drug-coated balloons and stents
Yesterday, delegates heard brand new data for drug-coated balloons (DCBs) in “wider use” scenarios such as challenging lesions; one-year results for a novel DCB; and late-breaking data on downstream coating effects of various DCBs. [...]
CX Venous Consensus Update: Take-home messages
The CX Venous Consensus Update—Plenary Programme took place on the first day of CX 2017 (Tuesday, 25 April). Stephen Black, member of the CX Programme Organising Board, summarises the take-home messages of this session. [...]
CX 2017: Peripheral Arterial Consensus highlights
The CX 2017 Peripheral Arterial Consensus Update Programme will focus on PATHWAYS OF CARE – whether to intervene, when and at what threshold, method and follow-up. "Over three days (25–27 April) there will be [...]